Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01088542 · ClinicalTrials.gov registry record · NA

The Community Youth Development Study: A Test of Communities That Care

A NA study of Depression and Anxiety, sponsored by University of Washington.

Active
Registry status
NA
Development phase
52,323
Enrollment target
1
Study location

NCT01088542: Active NA study of Depression and Anxiety, sponsored by University of Washington.

NCT01088542 is a NA study of Depression and Anxiety that is active but no longer recruiting, run by University of Washington. The registered enrollment target is 52,323 participants, above the 709-participant average among 679 other Depression trials with a reported enrollment target (7280% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01088542, a NA study of Depression and Anxiety, is active but no longer recruiting, sponsored by University of Washington.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
52,323 participants
Enrollment target
1
Study location

Study Summary

The Community Youth Development Study is an experimental test of the Communities That Care (CTC) prevention planning system. It has been designed to find out if communities that were trained to use the CTC system improved public health by reducing rates of adolescent drug use, delinquency, violence, and risky sexual behavior when compared to communities that did not use this approach. The primary purpose of the current continuation study is to investigate whether CTC has long-term effects on substance use, antisocial behavior, and violence, as well as secondary effects on educational attainment, mental health, and sexual risk behavior in young adults at ages 26 and 28. The continuation study also examines (a) how the interaction of social, normative, and legal marijuana contexts creates variation in the permissiveness of individuals' marijuana environments from late childhood to young adulthood and (b) whether, when, and for whom permissive marijuana environments increase marijuana and ATOD use and misuse from age 11 to 28 and interfere with the adoption of adult roles.

Primary Outcome

Surveys of the panel starting in 5th grade (2004) and continuing in grades 6-10, grade 12, and at ages 19, 21, and 23 are used to assess the impact of the intervention on risk and protective factors targeted by communities, substance use, delinquency, and violence. Cross-sectional surveys of all youth in grades 6, 8, 10, and 12 in all participating communities, conducted every 2 years from 2002 through 2012, are also used to assess the impact of the intervention on these primary outcomes.

Interventions

  • BEHAVIORAL Communities That Care

Study Locations (1)

Washington

  • University of Washington - Seattle

Trial Details

FieldValue
Enrollment Target 52,323 participants
Start Date 2003-10-01
Est. Completion 2025-06-30
Phase NA
University of Washington

1,048 total trials

What the registry record for NCT01088542 still lists

NCT01088542 is an interventional study that assigns participants to a tested intervention. Its 52,323 participants enrollment target places it among the larger protocols in the corpus, above the 709-participant average among 679 other Depression trials with a reported enrollment target (7280% higher).

The record links to 10 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Communities That Care is the first listed.

NCT01088542 reports a single indexed study location in Washington.

Frequently Asked Questions

What is clinical trial NCT01088542 about?

NCT01088542 is a clinical study titled "The Community Youth Development Study: A Test of Communities That Care". The Community Youth Development Study is an experimental test of the Communities That Care (CTC) prevention planning system. It has been designed to find out if communities that were trained to use the CTC system improved public health by reducing rates of adolescent drug use, delinquency, violence,...

What is the current status of trial NCT01088542?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 52,323 participants. The study started on 2003-10-01. Estimated completion is 2025-06-30.

What conditions does trial NCT01088542 study?

This clinical trial studies the following conditions: Depression, Anxiety, Suicide, Substance Abuse, Sexual Behavior.

What interventions are being tested in trial NCT01088542?

The interventions under investigation include: Communities That Care (BEHAVIORAL).

Who is sponsoring clinical trial NCT01088542?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01088542 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01088542's enrollment target sits among peer trials

52,323 3rd of 679 higher than 677 of 679 other Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05975671 · 52,500 participants · NA

    Reducing Empiric VAncomycin Use in Pediatric Suspected Sepsis

  • NCT06355934 · 52,121 participants

    OverTTuRe: Characteristics, Treatment Patterns and Outcomes of Patients With ATTR Amyloidosis

  • NCT07224243 · 54,000 participants · NA

    Impact of Intraoperative Oxygenation Practices on Patient Outcomes

  • NCT00500123 · 50,000 participants

    The Alpha-1 Foundation's and University of Florida's Alpha-1 Coded Testing (ACT) Study

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Source: ClinicalTrials.gov NCT01088542, the US trial registry maintained by the National Library of Medicine. NCT01088542 (large enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.